121 related articles for article (PubMed ID: 10450183)
21. Diagnosis of bladder cancer using telomerase activity in voided urine.
Cheng CW; Chueh SC; Chern HD
J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
[TBL] [Abstract][Full Text] [Related]
22. Urine biomarkers may someday detect even distant tumors.
Schmidt C
J Natl Cancer Inst; 2009 Jan; 101(1):8-10. PubMed ID: 19116386
[No Abstract] [Full Text] [Related]
23. Outer membrane vesicles alter inflammation and coagulation mediators.
Soult MC; Dobrydneva Y; Wahab KH; Britt LD; Sullivan CJ
J Surg Res; 2014 Nov; 192(1):134-42. PubMed ID: 24909870
[TBL] [Abstract][Full Text] [Related]
24. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
[TBL] [Abstract][Full Text] [Related]
25. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
Osterud B; Due J
Scand J Haematol; 1984 Mar; 32(3):258-64. PubMed ID: 6199833
[TBL] [Abstract][Full Text] [Related]
26. Urinary tissue factor activity in malignancy.
Carty N; Taylor I; Roath OS; el-Baruni K; Francis JL
Thromb Res; 1990 Feb; 57(3):473-8. PubMed ID: 2315897
[No Abstract] [Full Text] [Related]
27. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
28. A novel coagulation assay incorporating adherent endothelial cells in thromboelastometry.
Zipperle J; Schlimp CJ; Holnthoner W; Husa AM; Nürnberger S; Redl H; Schöchl H
Thromb Haemost; 2013 May; 109(5):869-77. PubMed ID: 23494019
[TBL] [Abstract][Full Text] [Related]
29. A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activity.
Jiang W; Kou J; Yuan S; Sun L; Yu B
J Biomol Screen; 2011 Mar; 16(3):295-302. PubMed ID: 21310849
[TBL] [Abstract][Full Text] [Related]
30. Relevance of urine telomerase in the diagnosis of bladder cancer.
Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.
Mani H; Hesse C; Stratmann G; Lindhoff-Last E
Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190
[TBL] [Abstract][Full Text] [Related]
32. Beta-cryptoxanthin and lung cancer in Shanghai, China--an examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure.
Stram DO; Yuan JM; Chan KK; Gao YT; Ross RK; Yu MC
Nutr Cancer; 2007; 57(2):123-9. PubMed ID: 17571944
[TBL] [Abstract][Full Text] [Related]
33. Tissue factor in infection and severe inflammation.
Levi M; van der Poll T; ten Cate H
Semin Thromb Hemost; 2006 Feb; 32(1):33-9. PubMed ID: 16479460
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
[TBL] [Abstract][Full Text] [Related]
35. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.
Ernofsson M; Thelin S; Siegbahn A
J Thorac Cardiovasc Surg; 1997 Mar; 113(3):576-84. PubMed ID: 9081105
[TBL] [Abstract][Full Text] [Related]
36. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.
Edwards RL; Levine JB; Green R; Duffy M; Mathews E; Brande W; Rickles FR
Gastroenterology; 1987 Feb; 92(2):329-37. PubMed ID: 3792769
[TBL] [Abstract][Full Text] [Related]
37. Expression and localization of tissue factor-based procoagulant activity (PCA) in pigeon monocyte-derived macrophages.
Gupta M; Doellgast GJ; Cheng T; Lewis JC
Thromb Haemost; 1993 Dec; 70(6):963-9. PubMed ID: 8165619
[TBL] [Abstract][Full Text] [Related]
38. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients.
Morgan D; Edwards RL; Rickles FR
Haemostasis; 1988; 18(1):55-65. PubMed ID: 3047024
[TBL] [Abstract][Full Text] [Related]
39. Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.
Chatziharalambous D; Lygirou V; Latosinska A; Stravodimos K; Vlahou A; Jankowski V; Zoidakis J
PLoS One; 2016; 11(2):e0149471. PubMed ID: 26889680
[TBL] [Abstract][Full Text] [Related]
40. Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy.
Ivanova EA; Orekhov AN
J Immunol Res; 2016; 2016():4789279. PubMed ID: 26885534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
